Showing results (351-360 of 401) with videos related to
Sort By:
Pageof 41
Anticancer Research|September 21, 2012
Gemcitabine-induced pulmonary toxicityDow-Chung Chi, Frances Brogan, Ithamar Turenne, et al.Resident and Staff Physician|November 12, 2021
Henoch-Schönlein Purpura Presenting as a Rash and Proteinuria in a 59-Year-Old WomanMuhammad Wasif Saif, Diane L Whitaker-Worth, Joseph Palmisano, et al.Cancer Medicine Journal|July 1, 2020
Review of Oncology and Transplant Literature for the Management of Hepatic and Pancreatic Resections in Jehovah's WitnessesHassan Aziz, Yuri Genyk, Muhammad Wasif Saif, et al.Anticancer Research|August 27, 2011
The efficacy of gemcitabine as salvage treatment in patients with refractory advanced colorectal cancer (CRC): a single institution experienceMuhammad Wasif Saif, Kristin Kaley, Robin Penney, et al.Oncology Letters|August 15, 2014
Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinomaMuhammad Wasif Saif, Leslie Ledbetter, Kristin Kaley, et al.Cutaneous and Ocular Toxicology|March 20, 2010
Unilateral hand-foot syndrome: an extraordinary side effect of capecitabineUmut Disel, Ozlem Gürkut, Hüseyin Abali, et al.Revista Do Instituto De Medicina Tropical De Sao Paulo|May 16, 2006
Pulmonary thromboembolism in AIDS patient with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: a case report and pathophysiology reviewJuan José Cortez-Escalante, Cleudson Castro, Gustavo Adolfo Sierra Romero, et al.Cancer Medicine Journal|November 16, 2020
Hepatectomy for Breast Cancer Metastasis and Sarcoma are more likely to have Adverse Outcomes than Hepatectomy for Primary Hepatocellular Cancer or for Colorectal MetastasisHassan Aziz, Kamil Hanna, Muhammad Wasif Saif, et al.Anti-Cancer Drugs|September 1, 2007
Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfateStephen H Wrzesinski, Meghan L McGurk, Constance T Donovan, et al.Journal of Pancreatic Cancer|February 22, 2019
Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine TumorsMuhammad Wasif Saif, Julie Fu, Melissa H Smith, et al.Pageof 41